January newsletter

Two new companies to enter CGT Catapult manufacturing centre 

Cell and Gene Therapy Catapult has well and truly hit the ground running in 2018 with the announcements of two new companies entering the CGT Catapult manufacturing centre. Adaptimmune and Freeline will both be entering the centre to develop viral vector manufacturing processes.